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Abstract
Inflammatory Bowel Disease encompasses two diseases, Crohn’s Disease and Ulcerative Colitis. During the last 70 years the
evolving of diet in the industrialized countries has led to the utilization of foods that have been processed rather than those in
their more natural original state. This increase in the processing of foods has been correlated with the more recent occurrence
of metabolic diseases such as Inflammatory Bowel Disease. Patients suffering from this problem exhibit lesser amounts of anti-inflammatory bacteria such as Roseburia and Faecalibacterium and increased amounts of pro-inflammatory bacteria Escheria
and Fusobacterium. Since diet directly alters the composition of the gut biome, this review aims to define the role of diet in the
pathogenesis and management of Inflammatory Bowel Disease.
Abbreviations:
IBD – Inflammatory Bowel Disease
CD – Crohn’s Disease
UC - Ulcerative Colitis

Introduction
What is Inflammatory Bowel Disease?
Inflammatory Bowel Disease (IBD) encompasses two diseases,
Crohn’s Disease (CD) and Ulcerative Colitis (UC). CD is characterized by inflammation of the digestive tract anywhere from
mouth to anus. In CD inflammation may reach through many
layers of the walls of the gastrointestinal tract causing severe
tissue damage. However, UC occurs when there is an inflammation of the colon and the rectum. In UC, the inflammation only
affects the innermost layer of the lining of the colon. There are
many symptoms for CD and UC. Some of the more common
ones include diarrhea, abdominal pain, cramping, blood in stool,
reduced appetite, unintended weight loss and severe bowel constriction (Conners, et al., 2017). Many times, inflammation is so
severe that the intestinal tissue is damaged beyond repair. In the
event of such inflammation the damaged tissue is removed via
colectomy. IBD tends to affect individuals of all ages. However,
IBD is most commonly found in individuals at a young age, interfering with education, work ability, social interaction and basic
quality of life. Therefore, researchers feel compelled to find resolutions for this disease (Lovasz, et.al., 2013).

How the Diet has Changed
Over the centuries the western diet has changed incredibly. In
the traditional diet, food was produced and consumed shortly
after harvest. In contrast, much of today’s food supply is processed, modified, and transported over great distances before
being ingested. In recent years, the western diet has been dominated by an increased consumption of refined sugars, omega-6
polyunsaturated fats and fast food, in addition to a deficiency
in fruits, vegetables and fiber. The western diet is prevalent in
industrial countries such as the United States, Canada, Western
Europe, Australia, and New Zealand, and has been spreading
and reaching newly developing countries as well (Lovasz, et.al.,
2013).This change in diet has led to the worldwide development
of many metabolic diseases, such as IBD. (Ng, 2013) (Moschen,
2012). Recent studies indicate that the incidence rate of IBD in
developing industrial countries has been increasing in the past
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50 years. This increase suggests that IBD may be triggered by an
environmental factor (Martinez & Chang, 2013). Although many
studies have been done, there is still no definite pathogenic
pathway nor cure for this disease.
Recent research suggests that diet is the key environmental risk factor in IBD pathogenesis. IBD is an intestinal disease
and is associated with a dysbiosis in the gut microbiota, the
microbe population found in the intestine (Reddavide, et al.,
2018). In general, IBD patients have been found to have lower
amounts of anti-inflammatory bacteria such as Roseburia and
Faecalibacterium and have increased amounts of pro-inflammatory bacteria Escheria and Fusobacterium (Aleksandrova, et.al.,
2017). Many studies have shown that one’s diet directly alters
microbe composition, making diet a pivotal risk factor of IBD.
Moreover, changes to the traditional diet of newly industrialized
countries can be linked to the increasing incidence of IBD. The
purpose of this review is to define the role of diet in the pathogenesis and management of IBD.

Methods
Critical analysis of peer reviewed articles and clinical research
papers were used to write this review paper. Articles were obtained from the Touro College online library in order to determine the relationship between diet and IBD.

Discussion:
IBD and Gut Microbes
The gut microbiome is an ecosystem, often referred to as a
Super Organ (Dolan, 2017). The microbes live in a symbiont
relationship with the host, performing beneficial tasks such as
nutrient production, development and maturation, regulation
of immune system and preventing the growth of harmful microorganisms (Aleksandrova, et.al. 2017). Dysbiosis, which is an
alteration to the gut flora, can cause disruption to these vital
tasks. Several studies show that IBD is correlated with altered
composition of gut microbes in the intestines.
Interestingly, Studies have shown, that there is an age-related
variation of IBD onset with three distinct stages. Early onset is
less than 10 years of age, with a peak onset at 15-30 years old, and
late onset cases occur at 60 years old.These changes correspond
to the change in the microbiome’s stability and diversity. Early
life is associated with a microbiome of minimal complexity and
stability and can be affected by diet change, illness and puberty.
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As individuals reach adulthood, the microbiome stabilizes and
shows improved resilience, but the composition may be altered.
Correspondingly, decreased stability is often observed in the elderly (Kostic, et.al., 2013). Considering this, the microbe composition and stability in the gut is a key factor in IBD progression.
One role of the microbiota is to maintain a healthy mucosa
by the production of anti-inflammatory interleukins. This is the
production of SCFA- short chain fatty acids such as butyrate,
succinate, lactate, phenols, thiols, and indoles (Reddavide, et al.,
2018). These SCFA act as energy for colonocytes which protect
against inflammatory responses (Frank, 2007). Patients suffering from IBD have reduced levels of beneficial SCFA producers
Bacteroidetes, Lachnuspiraceace, and Ruminococcaceae (Martinez &
Chang, 2013). An Additional study shows that IBD patients show
reduced levels of several other SCFA producing bacteria such as
Calibacterium praunsnizti and Roseburia (Dolan, 2017). This shows
a direct link between dysbiosis and IBD.
Another task of the gut microbiome is to maintain the mucus
layer of the colon and the small intestine. If the mucus layer is intact the gut flora will not directly interact with the epithelial cells
and inflammation will not occur. However, there is an adherent
invasive strain of E. coli that is found in abundance in IBD patients
compared with controls. These invasive bacteria can potentially
invade epithelial tissue and induce granuloma formation during
inflammation. A second group of invasive bacteria Fusobacteria
is found in abundance in the colon mucosa of IBD patients.
Fusobacterium varium have been found to cause colon mucosa
erosion, indicating the possibility of the influence of Fusobacterium
varium on the pathogenesis of IBD (Kostic, et. al. , 2013).
Bile Acid signaling is another point where host, microbe and
even dietary factors all come together. Bile acids assist in digestion and emulsification of fats to be absorbed in the intestines.
These bile acids are made in the liver from cholesterol. After
undergoing conjugation to glycine or taurine, the bile acids are
released in to the digestive tract. In the intestines, deconjugation of bile acids occurs through Bile Salt hydroxylase (BSH)
enzymes, making the bile acids functional. These BSH enzymes
are made exclusively by bacteria, making the bile acid composition in the intestine dependent on the microbiota composition.
The two products of bile acid metabolism act as ligands for
FXR (Farnesoid X receptor) and TGR5 (G protein-coupled bile
acid receptor 1), which act as signals for anti-inflammatory and
barrier function. It was found that IBD patients have increased
levels of conjugated bile acids compared to the control group,
making these patients prone to inflammation. Furthermore,
when bile acids are increased in the gut, it can promote growth
of pathobionts such as Bilophila Wadsworth, which is known to
induce inflammation (Dolan, 2017).
On the other hand, many microbes perform protective tasks
when enriched in the host. Bacteroides and Clostridium species
have been shown to cause expansion of T-cells and reduce

inflammation. Additionally, many bacteria can reduce intestinal
inflammation by regulating nuclear factor (NF)κB activation.
Faecalibacterium praunsnizti has anti-inflammatory properties
and is underrepresented in patients with IBD. Many species, such
as Bifidobacterium, Lactobacillus and Faecalibacterium, protect the
host from mucosal inflammation by down regulating inflammatory cytokines or stimulating IL-10 anti-inflammatory cytokines
(Kostic, et. al., 2013). Lastly, intestines rich in Bacteroidetes are
shown to initiate host responses that protect the host from
lethal infectious colitis (Brown, et. al., 2012).
Due to this connection between IBD and dysbiosis, there
are many current treatments for IBD that are directed at the
microbiota. Many antibiotics such as ciprofloxacin, metronidazole, the combination of both rifaximin and anti-tuberculous
regimens are used to treat IBD (Nitzan, et.al., 2016). Normally
antibiotics may cause thinning of the mucus layer, weakening the
barrier function, leading to increased gut infections. Additionally,
antibiotics tend to cause an increase in E. coli composition in
the gut, which is a distinctive feature in intestinal inflammation.
However, studies show that brief exposure to antibiotics causes
slight changes to the microbiota in IBD patients that provides
relief from symptoms. Alternatively, repeated exposure of the
same antibiotic causes persistent changes to the microbiota
leading to infection (Kostic, et.al., 2013). Due to this controversy of antibiotics, in the last few years methods to repopulate the gut with healthy beneficial microbes has been gaining
popularity as a potential treatment for IBD. Evidence shows
that Fecal Microbiota Transplantation (FMT) can be effective in
replenishing a healthy microbiota. FMT, also known as a stool
transplant, is the transplantation of gut microbes from the stool
of a healthy individual into the recipient. There has been a high
success rate for FMT in many other metabolic diseases such
as relapsing C. difficile infection. Therefore, researchers are considering FMT for other gastrointestinal illnesses such as IBD.
Additional studies are needed to determine the outcome of
FMT on IBD patients (Kostic, et.al., 2013).
It is now clear that IBD is inherently linked with dysbiosis.
There are many factors that can cause dysbiosis such as genetics, immune function, and diet. Genetic susceptibility is the most
obvious factor. IBD patients carrying a mutation in a NOD2
related gene, have increased numbers of mucosa adherent bacteria, as well as significant alterations in bacterial composition
(Kostic, et. al., 2013). Studies have shown that CD is common in
the Ashkenazi Jewish population. Many studies were done using
large families of Ashkenazi Jews to determine a genetic variant cause to CD. One study found the haplotype 268SJW1 on
chromosome 16 to contribute to the risk of CD in Ashkenazi
Jews (Sugimura, 2003). Although genetic susceptibility cannot be
ignored, due to the increasing incidence rates of IBD, researchers believe that environmental factors are the core triggers.
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Dietary Factors effecting the Microbiome
Diet is suspected to be the prime contributor to the pathogenesis of IBD. Dietary composition has been proven to be
associated with intestinal inflammation by directly or indirectly modifying the gut microbiome (Reddavide, et al., 2018). So,
current research is aimed at examining how diet changes the
microbiome and how these changes affect the host, in order
to determine foods that can cause or prevent inflammation
(Kostic, et.al., 2013).
In a study done, subjects were put on a western-style diet for
one month and showed a 71% increase in plasma endotoxins.
The western diet is characterized by a high fat diet and therefore
may cause endotoxemia by causing changes in the intestinal barrier function or microbiota composition (Pendyala, et.al., 2012).
Another study showed that mice fed a high fat diet were associated
with endotoxemia and systemic inflammation. These mice showed
lowered amounts of Bifidobacterium spp, indicating that this species
of bacteria have anti-inflammatory properties (Cani, 2007).
Variations in long term diet patterns change the ratios of
Bacteroides, Prevetolla, and Firmicutes. However, modifications in
short term diets have no significant influence. It has been determined that enriched protein and animal fat diets, common in the
western diet, favored Bacteroides. Diets rich in carbohydrates,
such as in agrarian societies, favored Prevetolla (Wu, 2011).
Switching to a high fat diet causes a decrease in Bacteroides and
an increase of Firmicutes and Proteobacteria (Hildebrandt, 2009).
It has been proven that protein rich diets increase enzymes that
produce toxic metabolites which trigger inflammatory response
(Brown, DeCoffe, et.al., 2012).
Another microbe often associated with IBD inflammation
is Bilophila Wadsworth, a sulfite producing bacteria. In a recent
study when mice were fed a milk fat enriched diet, it led to
a series of reactions that ultimately led to an abundance of
Bilophila Wadsworth. Although there is no precise mechanism for
how it causes inflammation, there are many hypotheses (Frank,
2007). Furthermore, an interesting study concluded that refined
dietary glucose intake can change microbe composition and increase intestinal inflammation (Whitehead, 2011). A strict Vegan
or Vegetarian diet led to a significant reduction in Bacteroides
spp, Bifidobacterium spp, and the Enterobactericeae which helps
manage inflammation of IBD (Enck, 2011).
A further connection between diet, microbes, and host inflammation has been discovered through studies of the intestinal function of the aryl hydrocarbon receptor (AhR). AhR is
a nuclear receptor that activates certain metabolic genes. AhR
also plays a key role in adaptive immunity through the regulation of T-cell activity. IBD patients have a decreased expression
of AhR which may cause pro-inflammatory immune activation
conditions. It has been discovered that certain gut microbes can
produce AhR agonists. IBD patients contain less amounts of the
microbes necessary to produce these agonists. An important
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dietary source of AhR ligands are found in cruciferous vegetables such as cauliflower, broccoli, brussels sprouts and bok choy.
This may explain why these vegetables have a protective effect
on IBD risk (Dolan, 2017).
One major role of the microbiota is to act as an immune system of the host. The gut flora protects the host from pathogens
by maintaining the integrity of the intestinal mucosa. Dysbiosis
can cause a disruption in the intestinal mucosa and allow access
for pathogens which can lead to reactions which cause inflammation and eventually tissue damage. Many studies were conducted
to determine the influence of micro and macro nutrients on immunity. Many micronutrients are essential for immunonutrition
such as vitamins A, C, D, E, folic acid, zinc, and iron (Reddavide, et
al., 2018). Deficiencies in vitamins A and D may reduce function
of natural killer cells, while supplemental zinc and vitamin C
can increase their activity. Vitamin D is important in intestinal
function for it is known to suppress microbial invasion into the
epithelium. 82% of IBD patients have been found to have vitamin
D deficiencies which have been linked to a weakened epithelial
barrier. Although studies have been done to determine the effects of vitamin D supplements on IBD patients, more research
is needed. Furthermore, Iron deficiencies have been associated
with faulty T cell response and weakened cytokine production.
However, iron supplements have been shown to have a negative
effect on IBD patients by increasing an individual’s susceptibility to infections. It is evident that micronutrients can affect the
immune system thereby causing dysbiosis and the onset of IBD
(Aleksandrova, et.al., 2017). More research is needed to recognize optimal nutrient levels and therapeutic options.
These findings support the fact that the microbiota is directly related to food quality. Diet influences the composition
of the microbiota and thereby controls IBD pathogenesis. The
current diet is significantly different than the diet of previous
generations when the prevalence of IBD was not as widespread.
Countless experiments were performed to see the effects of
diet on IBD. Dietary factors can have a negative effect on IBD
and increase inflammation, or they can have a protective or even
healing effect on patients with IBD.

Dietary Risk Factors of IBD
Refined and processed carbohydrates are risk factors for IBD,
but complex carbohydrates, such as fruits, vegetables, or fibers
can help manage IBD. A diet high in animal protein was correlated with a 3.3-fold increased risk in IBD (Reddavide, et al.,
2018). Individuals that consumed milk products including milk,
yogurt and cheese, had a lower chance of developing IBD. This
suggests that dairy intake has no risk effect on IBD and may
even have a protective effect (Malavia, 2017). Many studies were
done on the effects of fat intake on IBD. Although it is known
that a typical high fat western diet has a negative effect on IBD,
it is unclear which specific fats cause that. One study showed
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that an increase in poly-unsaturated fatty acids was positively
associated with IBD (Parekh, 2015). Another study concluded
that long term intake of trans-unsaturated fatty acids is associated with a trend towards IBD. Evidence shows that excessive
consumption of omega-6 poly-unsaturated fatty acids increases
the risk of IBD, while consumption of omega-3 poly unsaturated
fatty acids is associated with a decrease in one’s risk for the
onset of the disease (Brown, et. al., 2012).

Dietary Management in IBD
Interestingly, research has shown that the Mediterranean Diet, due
to its unique balance of fat, is directly correlated with decreased
inflammation. The Mediterranean Diet (MD) is characterized by
fruits and vegetables rich in fiber, vitamins, and antioxidants, whole
grains, and nuts, as well as olive oil and oily fish that are high in
poly and mono unsaturated fatty acids. Each item in the diet provides benefits to patients with IBD (Serra-Majem, 2009).
Legumes, a major part of the MD, contain soluble fibers that
do not aggravate the gut microbes. Furthermore, legumes tend
to have a prebiotic action and promote the growth of beneficial
SCFA producing microbes which protect the gut mucosa. Fruits
and vegetables have a naturally high fiber content and therefore
using a juicer to extract the essential vitamins and minerals
showed best results when treating IBD patients. Recent studies
claim that olive oil has ani-inflammatory effects.This is due to the
synergic action of its oleic acid with other antioxidant molecules.
Grains that were proven to have the most beneficial effect were
unmodified grains. These grains have low immunogenic impact
and do not cause inflammation in the gut mucosa. Bluefish, which
is popular in the MD, is shown to have anti-inflammatory effects
due to its omega-3 fats EPA and DHA (Reddavide, et al., 2018).
An alternative diet that has shown promise in IBD management is the Specific Carbohydrate Diet (SCD). This diet works
with the hypothesis that patients with IBD can not break down
disaccharides and amylopectin. Large amounts of disaccharides
can lead to an over growth of microbes and cause IBD related symptoms. Therefore, the SCD is a strict monosaccharides
diet excluding disaccharides and most polysaccharides. The diet
includes vegetables with a high amylose to amylopectin ratio.
The real potential for this diet is in the maintenance of IBD
patients in remission to help maintain a healthy gut microbiome
(Reddavide, et al., 2018). A similar diet the FODMAP – Low
Fermentable oligosaccharide disaccharide monosaccharide and
polyols diet also showed significant improvement of symptoms
in patients with IBD (Dolan, 2017). Although these findings
clearly define the effects of diet on IBD, the role of diet does
not stop there.

Dietary Factors and Epigenetics
New emerging evidence points to epigenetics as a major component of IBD pathogenesis. Epigenetics is the study of heritable

changes in gene expression that do not involve changes in the
actual DNA sequence.This leads to a change in phenotype without a change in genotype. Epigenetic modifications, such as histone modifications, influence DNA accessibility and chromatin
structure, thereby effecting the regulation of gene expression.
The body uses epigenetic modifications as natural ways to control gene expression as needed throughout one’s life. However,
epigenetic changes can also be induced by external factors including age, the environment, lifestyle, and disease state. Dietary
factors have been shown to contribute to IBD in an indirect
manner via epigenetics (Reddavide, et al., 2018).
Over time, researchers have discovered new methylation
patterns emerging for IBD. Many therapeutic studies were done
to try to counteract this methylation using drugs and other
processes. However, researchers found it difficult to pinpoint
the methylation in specific tissue and to predict drug response
in clinical trials so other strategies were considered. Dietary
factors have been known to alter epigenetics which can influence an immune response that can potentially offset inflammation. Therefore, scientists looked at dietary components
for a solution to IBD methylation patterns. It was discovered
that secondary plant metabolites, such as polyphenols, have
been demonstrated to inhibit DNA methyltransferase activity.
Furthermore, gut microbiome has been shown to alter host
histone acetylation and methylation in human colon tissues.
Interestingly, SCFA, which is generally produced from microbial
fermentation of fibers, is shown to be important in epigenetic
regulation of inflammatory responses. It was determined that
a lack of SCFA can disturb chromatin effects. This deficiency of
SCFA can be a result of a diet low in fiber or a decrease in beneficial SCFA producing bacteria. As mentioned previously, IBD
patients have been found to have low amounts of Bacteroidetes,
Lachnuspiraceace, Ruminococcaceae, Calibacterium praunsnizti, and
Roseburia, SCFA producing bacteria, making IBD patients susceptible to epigenetic changes which can lead to inflammation.
(Reddavide, et al., 2018).

Other Environmental Factors
Although diet has been presumed to be the primary trigger for
IBD, there are many other environmental factors that can prompt
IBD symptoms. Smoking, and stress are such factors that have
also been shown to influence IBD pathogenesis. Interestingly,
Smoking has been found to be negatively associated with UC
but positively associated with CD. Patients who did smoke
only developed UC after they ceased smoking. Additionally,
male UC patients who smoked during disease progression, reported reduced symptoms and had lower hospitalization rates
compared to non-smokers. Increased colectomy rates were
seen in non-smokers and ex-smokers than in current smokers. Also, reduced rates of relapse were seen in patients who
began smoking after the onset of UC. On the other hand, many
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studies show an increased risk of CD in smokers compared to
non-smokers. There is a 34% increased relapse rate for CD in
smokers. Furthermore, severe lesions at the anatomic sight have
developed more in smokers than non or ex-smokers in CD
patients (Thomas, et.al., 2000).
There are many theories for the possible mechanism of the
influence smoking has on IBD. Firstly, due to the interrelationship
of gut microbes and immunity, researchers studied how smoking influences the immune system. Studies show that changes in
T cells, such as increased levels of suppressor OKT8+ cells and
a decreased ratio of OKT4+ to OKT8+ cells have been seen
in heavy smokers. Remarkably, these changes revert to normal
range once a patient terminates smoking. The low levels of IgA’s
in the saliva and intestinal secretion of smokers dictates an additional immune effect.The IgA antibody is a vital component of secretions that lubricate the mucosal surfaces which act as the first
line of defense in the immune system. Therefore, patients who
smoke will already have a weakened immune system. Another
possible mechanism involves the inflammatory pathway. Nicotine,
a substance found in most cigars and cigarettes, is known to
effect cytokine production in the body, specifically by reducing
pro-inflammatory cytokines. Also, certain eicosanoids, which are
correlated with inflammation, are seen in decreased amounts in
smokers. This may be the cause to the negative effect of smoking
on UC patients. Nevertheless, smokers show lower levels of two
interleukins, IL-1β and IL-8, which help regulate inflammatory
response. Lastly, smoking may also influence IBD via intestinal
mobility. One major symptom of IBD is issues with bowel movement and defecation. It has been found that nicotine can affect
the intestinal motility at many sites. Nicotine relaxes the smooth
muscles of the intestine and therefore reduces contractile activity
during bowel movement (Bhatti, 1997). These mechanisms portray the direct influence that smoking may have on IBD.
Another environmental factor that researchers have discovered to be effective in the pathogenesis of IBD, is stress related
influences. In earlier years IBD was classified as a psychosomatic
disorder. Although this classification had been long disproved, it
does represent the deep relationship between stress and IBD.
In general, stress acts as a threat to an organism’s homeostasis.
Therefore, the body will exert mechanisms to maintain equilibrium in the face of any stress. There are two interconnected
pathways in the body that govern stress related responses; the
HPA axis - hypothalamic pituitary adrenal axis and the ANS - autonomic nervous system. The pathway of the HPA axis begins
when stress stimulates the release of corticotropin releasing
hormone from the hypothalamus. This causes the release of adrenocorticotropic hormone from the anterior pituitary gland
which then stimulates the secretion of cortisol from the adrenal cortex. Cortisol then travels throughout the blood stream
causing changes all around the body to help deal with stress. The
pathway of the ANS involves the stress induced activation of
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pontomedullary nuclei, which control autonomic responses. As
a response to stress, adrenaline and noradrenaline are released
from the adrenal medulla via the stimulation of the sympathetic
nervous system. Furthermore, The HPA axis and ANS are key
modulators of the rich nerve supply of the gut, the ENS – enteric
nervous system. The ENS is composed of 100 million neurons
that regulate functions of the gastrointestinal tract. The term
“Brain-Gut Axis” refers to this complex network of neurons of
the HPA axis, ANS, and ENS (Mawdsley, 2005).
The actual pathway of the Brain-gut axis response to stress is
complex. Various interconnected activities occur in both the gut
and around the body in response to stress that can lead to inflammation. Specifically, in the gut, in response to stress, inflammatory
cytokines, SCFA, and microbial products can alter the ANS and in
turn lead to the secretion of cortisol and adrenaline. Also, under
stress, the gut microbiota and mast cells can release various
chemicals such as histamine or serotonin which are known to
impair the intestinal secretion and intestinal mucosa, which can
lead to inflammation.There are many stressors that can affect the
intestinal mucosa’s permeability, making a host predisposed for
infections and inflammation (Brzozowski, 2016).
Due to this intimate correlation between the nervous system
and the gut, it is obvious that stress can influence the pathogenesis of IBD. Chronic heightened stress has been determined
to have an important role in predicting the relapse of IBD in
patients in remission (Mawdsley, 2005). Also, mice that were
induced with depression demonstrated an increase in inflammation which was modulated by an increase in pro-inflammatory cytokines secreted by macrophages (Brzozowski, 2016).
Although researchers have not determined an absolute direct
pathway for the control of stress on inflammation, there are
many suggestions. Many propose that patients with IBD have
altered HPA axis functioning, which may explain the relation
of stress to IBD symptoms. Interestingly, cortisol, which is
released under stress, is known to have anti-inflammatory effects. However, in patients with UC, levels of cortisol showed
no correlation to the levels of inflammatory cytokines. On the
other hand, others hypothesized that due to the high levels of
inflammatory cytokines in the blood of active IBD patients, the
response of the HPA axis and thereby the response of cortisol
may be dampened. Likewise, stress is known to impact gastrointestinal motility, and water and ion secretion. While these are
non-inflammatory effects, they may contribute to the non-inflammatory symptoms of IBD patients (Mawdsley, 2005). The
above mechanisms demonstrate the correlation between stress
and IBD, making psychological factors a key influence in the
pathogenesis of IBD.

Conclusion
The intestinal microbiota performs vital jobs in host metabolism making its composition vital to the host’s health. Dysbiosis,
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which is found in IBD, can be caused by several different factors.
While genetics and other environmental factors cannot be ignored, an altered microbiota resulting from diet-induced dysbiosis may also be a factor that contributes to the inappropriate
inflammatory responses that occur. As our understanding of the
microbiota continues to grow, promoting microbes to prevent
or control inflammatory-mediated diseases through diet may
represent an exciting therapeutic avenue.
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